Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Human medicines European public assessment report (EPAR): Aujemflu, Influenza vaccine (surface antigen, inactivated, adjuvanted, prepared in cell culture), Status: Opinion
Source: